Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Baxter
Harvard Business School
McKesson

Last Updated: December 10, 2019

DrugPatentWatch Database Preview

Litigation Details for Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-03-27
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand Plaintiff Referred To
Parties DR. FALK PHARMA GMBH; SALIX PHARMACEUTICALS, INC.; TEVA PHARMACEUTICALS USA, INC.
Patents 4,138,475; 4,395,421; 4,496,553; 5,541,170; 5,643,602; 6,423,340; 6,551,620; 8,337,886; 8,496,965; 8,865,688
Attorneys Andrew Russell; Dana Kathryn Severance; Daniel Marcus Attaway; Kristen Healey Cramer; Mary W. Bourke
Link to Docket External link to docket
Small Molecule Drugs cited in Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-03-27 1 Exhibit A (Continued) 4,138,475 A 2/1979 McAinsh et al. 4,432,966… United States Patent (10) Patent No.: US 8,865,688…factors such as the disease state, age, and patents, patent applications, articles, books, and treatises… 5 The contents of all references, patents, pending patent safety profile and was effective compared… COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Teva Pharmaceuticals USA, Inc. External link to document
0000-00-00 29 Initial Infringement Contentions for U.S. Patent No. 8,865,688 filed by Dr. Falk Pharma GmbH, Salix Pharmaceuticals…2017 2 August 2019 1:17-cv-00329 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,865,688. (jcs) (Entered: …2017 2 August 2019 1:17-cv-00329 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 55 Notice of Service Final Infringement Contentions for U.S. Patent No. 8,865,688 filed by Dr. Falk Pharma GmbH, Salix Pharmaceuticals…2017 2 August 2019 1:17-cv-00329 830 Patent Plaintiff District Court, D. External link to document
0000-00-00 62 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,865,688. (Attachments: # 1 …2017 2 August 2019 1:17-cv-00329 830 Patent Plaintiff District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Colorcon
McKinsey
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.